Clinical Trial Update: All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the combination of All-Trans Retinoic Acid (ATRA) and atezolizumab for recurrent or metastatic non-small cell lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• Atezolizumab (Tecentriq) (atezolizumab)

Snippet

Sponsor: Dwight Owen | Conditions: Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING